Skip to main content
SM

Skribe Medical

Skribe Medical develops battery-free, multi-sensor patches that enable continuous, wearable measurement of complex physiological signals for remote patient monitoring. The system is specifically designed to detect early signs of cardiotoxicity in patients undergoing cancer therapy. Utilizing deep learning algorithms and resonant body power technology, Skribe provides oncologists with simplified, actionable data reports for proactive cardiac care management.

San Francisco, United States3100+ followers
Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Cancer treatments, while effective, can cause irreversible heart damage, leading to cardiac complications and reduced lifespan for cancer survivors. Early detection of cardiotoxicity is challenging due to the unpredictable nature of heart damage caused by various cancer therapies. Current monitoring methods often fail to provide timely insights for effective intervention.

Solution

Skribe Medical offers a wireless wearable sensor that provides continuous heart-health monitoring for cancer patients during treatment and survivorship. The Band-Aid-like sensor integrates key diagnostic insights from echocardiogram, electrocardiogram, bioimpedance, and auscultation. This allows oncologists to gain predictive monitoring capabilities for both established and experimental treatments, enabling timely interventions to protect patients' hearts. The device aims to ensure that cancer survivors can live longer, healthier lives without the added worry of heart-related complications.

Target Audience

The primary target audience includes oncologists and cardiology specialists focused on cancer patients undergoing cardiotoxic treatments, as well as cancer survivors at risk of developing cardiac complications.

Features

  • Wireless, Band-Aid-like sensor for easy and continuous wearability
  • Integration of multiple diagnostic modalities: echocardiogram, electrocardiogram, bioimpedance, and auscultation
  • Predictive monitoring capabilities for early detection of cardiotoxicity
  • Real-time data streaming to enable timely clinical intervention
  • Battery-free operation for user convenience
  • Lightweight design for patient comfort
This profile is AI-generated and may contain inaccuracies.